86 related articles for article (PubMed ID: 9622936)
1. [Treatment of deep venous thrombosis at home: evolution from ideas to medical practice].
Boccalon H; Elias A; Chalé JJ; Cadene A; Dumoulin A
Bull Acad Natl Med; 1998; 182(1):101-12; discussion 112-5. PubMed ID: 9622936
[TBL] [Abstract][Full Text] [Related]
2. Home treatment of deep vein thrombosis: a two-years experience of a single institution.
Grau E; Real E; Pastor E; Viciano V; Aguiló J
Haematologica; 1998 May; 83(5):438-41. PubMed ID: 9658729
[TBL] [Abstract][Full Text] [Related]
3. [Protocol for ambulant treatment of deep venous thrombosis in a leg: efficacious and safe in general practice].
van Hulsteijn LH; Brenninkmeijer BJ; Trügg RA; Litjens-van de Ven AJ; Huisman MV
Ned Tijdschr Geneeskd; 2000 Mar; 144(12):557-60. PubMed ID: 10746047
[TBL] [Abstract][Full Text] [Related]
4. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression.
Labas P; Ohrádka B; Vladimír J; Cambal M
Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
6. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.
Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S
Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651
[TBL] [Abstract][Full Text] [Related]
7. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
9. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight heparin for deep vein thrombosis in glioma patients.
Schmidt F; Faul C; Dichgans J; Weller M
J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158
[TBL] [Abstract][Full Text] [Related]
11. [How to provide practical treatment for ambulatory patients with deep venous thrombosis].
Achkar A; Samama MM
J Mal Vasc; 1999 Feb; 24(1):58-65. PubMed ID: 10192039
[TBL] [Abstract][Full Text] [Related]
12. [Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis].
Alonso Martínez JL; Abínzano Guillén ML; Urbieta Echezarreta MA; Annichérico Sánchez FJ; Fernández Ladrón V; García Sanchotena JL
An Med Interna; 2008 Jan; 25(1):4-8. PubMed ID: 18377187
[TBL] [Abstract][Full Text] [Related]
13. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
[TBL] [Abstract][Full Text] [Related]
14. Outpatient treatment of deep venous thrombosis: a clinical care pathway managed by the emergency department.
Vinson DR; Berman DA
Ann Emerg Med; 2001 Mar; 37(3):251-8. PubMed ID: 11223760
[TBL] [Abstract][Full Text] [Related]
15. [The home treatment of deep venous thromboses with low-molecular-weight heparin].
Grau Segura E; Real Vila E; Pastor Guzmán E; Torró Richart JA; Garay Burdeos M
Rev Clin Esp; 1997 Jun; 197(6):398-401. PubMed ID: 9304129
[TBL] [Abstract][Full Text] [Related]
16. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis.
Naz R; Naz S; Mehboob M; Khalid GH
J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
Hauer KE
West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin (nadroparine) versus oral anticoagulant (acenocoumarol) in the long-term treatment of deep venous thrombosis: comparison of efficacy, safety and hospitalisation period in 105 patients.
Mazokopakis EE; Vrentzos GE; Ganotakis ES
Curr Med Res Opin; 2003; 19(6):565-6. PubMed ID: 14594529
[TBL] [Abstract][Full Text] [Related]
19. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
Brewer D
J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370
[TBL] [Abstract][Full Text] [Related]
20. Home-treatment of deep vein thrombosis in patients with cancer.
Ageno W; Grimwood R; Limbiati S; Dentali F; Steidl L; Wells PS
Haematologica; 2005 Feb; 90(2):220-4. PubMed ID: 15710575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
